Blincyto registered with KRW 2.48 million
An acute lymphoblastic leukemia treatment, Blincyto(blinatumomab) and a cell treatment for burn, Keraheal-Allo(cultured allogenic keratinocytes, kaloderm) will be newly registered in the drug insurance benefit list.
Upper limit prices of three products including CKD Gliatilin Inj(choline alfosc...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
